IN BRIEF: Haleon says Pfizer representative steps down from board

Haleon PLC - Weybridge, Surrey-based consumer healthcare firm that spun out of GSK PLC in 2022 - ...

Alliance News 25 February, 2025 | 4:15PM
Email Form Facebook Twitter LinkedIn RSS

Haleon PLC - Weybridge, Surrey-based consumer healthcare firm that spun out of GSK PLC in 2022 - Says Pfizer Inc representative Bryan Supran stepped down as a non-executive director on the Haleon board on Tuesday, following the reduction of Pfizer's stake in Haleon to less than 10%, and in line with the two firms' prior relationship agreement.

Haleon Chair Dave Lewis says: "On behalf of the board, I would like to thank Bryan for his contributions to the board's discussions and for being part of the Haleon journey from the initial joint-venture in 2019 through demerger to today. We wish him all the very best for the future."

Current stock price: 396.50 pence, down 0.1% in London on Tuesday afternoon

12-month change: up 22%

By Emily Parsons, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Haleon PLC 396.50 GBX -0.10
Pfizer Inc 26.74 USD 0.34

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures